期刊文献+

TB-Ab-IgG ADA和CEA对良恶性胸水鉴别诊断意义 被引量:19

Measuring TB-Ab-IgG,ADA and CEA for differentiation diagnosis value of bening and malignant pleural exudate
下载PDF
导出
摘要 目的 探讨胸水结核抗体 (TB Ab IgG)、腺苷脱氨酶 (ADA)、癌胚抗原 (CEA)联合检测对良恶性胸腔积液的鉴别价值。方法 采用DIGFA法、Giusti改良法和放射免疫法对 92例胸腔积液行胸水TB Ab IgG、ADA和CEA检测分析。 结果 TB Ab IgG在结核性、癌性和其它组胸腔积液中的阳性率分别是 81.8%、12 .8%和 1.1% ,特异性为 87.5 % ;ADA活性在结核性和癌性胸腔积液中分别为 (5 9.6± 2 8.8)U/L和 (2 4 .7± 11.5 )U/L(P <0 .0 1) ,CEA为 (8.5± 7.3)ng/mL和 (6 0 .2± 39.6 )ng/mL(P <0 .0 1) ,ADA在其它组胸腔积液中为 (44 .6± 2 6 .5 )U /L ,与结核性胸腔积液相比 (P >0 .0 5 )。结论 胸腔积液TB Ab IgG、ADA、CEA检测对良恶性胸腔积液有鉴别价值。 Objective To determine the differential diagnosis value of Mycobacterium tuberculosis antibody (TB-Ab-IgG),carcinoembryonic antigen (CEA) and adenosine deaminase (ADA) between benign and malignant pleural exudate.Methods The TB-Ab-IgG measured by DIGFA,ADA activity by the modified Giusti assays and CEA measured by IRMA in 92 cases of pleural exudate were analyzed.Results The positive rates of TB-Ab-IgG of tuberculous,malignant exudate and other group were 81.8%, 12.8% and 1.1% respectively,the specificity was 87.5%;the ADA activity of tuberculous and malignat exudate was (59.6±28.8)U/L and (24.7±11.5)U/L( P <0.01).The CEA levels were (8.7±7.3)ng/ml and (60.2±39.6)ng/ml( P <0.01);While the ADA activity of other group was (44.6±26.5)U/L,Compared with tuberculous exudate ( P >0.05).Conclusion The test of TB-Ab-IgG,ADA and CEA of pleural exudate is of great value of differentiate benign from malignant exudate.
出处 《中国防痨杂志》 CAS 北大核心 2004年第1期21-23,共3页 Chinese Journal of Antituberculosis
关键词 TB-Ab-IgG ADA CEA 胸水 鉴别诊断 胸腔积液 腺苷脱氨酶 癌胚抗原 结核抗体 Mycobacterium tuberculosis,Antiboby-Immunoglobulin G Carcinoembryonic antigen Adenosine deaminase Pleural exudate
  • 相关文献

参考文献4

二级参考文献28

  • 1侯瑛萍,孙巨笔,曹敬银.PPD和抗结核抗体对肺结核阳性率的考核观察[J].临床肺科杂志,1998,3(3):59-59. 被引量:1
  • 2崔云龙,王海燕,刘洁,李玲,周广军.两点法测定腺苷脱氨酶的改进[J].临床检验杂志,1994,12(4):185-185. 被引量:2
  • 3崔云龙,李玲,梁慧,郝钦芳.两点法测定腺苷脱氨酶及临床初步应用[J].中华医学检验杂志,1994,17(2):91-94. 被引量:9
  • 4戴广海 石延章 李春海 等.肺癌患者血浆GST—π水平测定及其临床意义[J].中华肿瘤杂志,1997,19:357-357.
  • 5Diez M,Torres A,Maestro ML,et al. Prediction of survival and recurrence by serum and cytosolic levels of CEA,CA125 and SCC antigen is repectable non small cell lung cancer. Cancer, 1996, 10(8) :1248~1254.
  • 6Sanchez De Cos J,Masa F,de la Cruz JL,et al. Squamous cell carcinoma antigen(SSC-Ag)in the diagnosis and prognosis of lung cancer. Chest, 1994,105(3): 773~ 776.
  • 7De Cos J, Masa F,de la Cruz JL.et al. Squamous cell carcinoma antigen (SCC Ag)in the diagnosis and prognosis of lung caner.Chest 1994,105(3) :773~776.
  • 8Vassilakopoulos T,Troupis T,Sotiropoulou C,et al. Diagnostic and prognostic significance of squamous cell carcinoma antigen in nonsmall cell lung cancer. Lung Cancer,2001,32(2) :137~ 144.
  • 9Niklinski J,Furman M, Laudanski J, Evaluation of squamous cell carcinoma antigen(SCC-Ag)in the diagnosis and follow-up of patients with non-small cell lung carcinoma. Neoplasma, 1992,39(5):279~282.
  • 10Niklinski J,Furman M,Moniuszko-Jakoniuk J,et al. SCC-Ag antigen in serum of paitents with primary non-small cell lung carcinoma. Pol Tyg Lek 1993 Jun 21-28;48(25-26):548~550.

共引文献245

同被引文献94

引证文献19

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部